Inclusion complexation of diazepam with different cyclodextrins in formulations for parenteral use

Pharmazie

Volumn 60, Issue 8, 2005, Pages 598-603

  Holvoet, C ^a   Vander Heyden, Y ^a   Plaizier Vercammen, J ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN SULFOBUTYL ETHER; CYCLODEXTRIN DERIVATIVE; DIAZEPAM; HYDROXYPROPYL GAMMA CYCLODEXTRIN; MALTOSYL BETA CYCLODEXTRIN; POVIDONE; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; COMPLEX FORMATION; CONCENTRATION RESPONSE; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STERILITY; FILTRATION; PH;

ALGORITHMS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLODEXTRINS; DIAZEPAM; EXCIPIENTS; HYPNOTICS AND SEDATIVES; INFUSIONS, PARENTERAL; PHARMACEUTICAL SOLUTIONS; SOLUBILITY; SOLVENTS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 23844480696     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. AHFS, American Hospital Formulary Service (2002), Drug Information. In: Gerald K (ed.) American Society of Health-system Pharmacists, Bethesda, MD, USA, pp. 2390-2392.
2. AVGI, Algemene vereniging van de Geneesmiddelenindustrie (2001) In: Ciaessens P (ed.), MediMedia Belgium, Brussels, Belgium, pp. 1851-1853.
3. 14C]diazepam. J Pharm Sci 79: 773-777.
4. Brewster ME, Anderson WR, Loftsson T, Huang MJ, Bodor N, Pop E (1995) Preparation, characterization, and anesthetic properties of 2-hydroxypropyl- β-cyclodextrin complexes of pregnanolone and pregnenolone in rat and mouse. J Pharm Sci 84: 1154-1159.
5. Connors K, Amidon GL, Stella VJ (1986) Chemical Stability of Pharmaceuticals, Handbook for Pharmacists, in: Wiley L and Sons (eds.), New York, pp. 413-420.
6. DAB, Deutsches Arzneibuch (1999) Kommentar zur Europäischen Pharmacopea, Arzneibuch-Kommentar Wissenschaftliche Erläuterungen zum Arzneibuch, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, pp. 1423-1428.
7. DeLuca PP, Boylan JC (1992) Formulation of small volume parenterals. In: Avis K, Lieberman H, and Lachman L (eds.), Pharmaceutical dosage forms: parenteral medications. Marcel Dekker, New York, pp. 173-248.
8. Duchêne D, Wouessidjewe D (1990) Physicochemical characteristics and pharmaceutical uses of cyclodextrin derivatives, part 1. Pharm Tech 12: 26-34.
9. rd edition supplement, Council of Europe, Strasbourg, France, pp. 729-730.
10. rd edition supplement, Council of Europe, Strasbourg, France.
11. Han WW, Yakatan GJ, Maness DD (1977) Kinetics and mechanisms of hydrolysis of 1,4 benzodiazepines II: oxazepam and diazepam. J Pharm Sci 66: 573-577.
12. Higuchi T, Connors KA (1965) Phase-solubility techniques. Adv Anal Chem Instrum 4: 117-212.
13. Holvoet C, Plaizier-Vercammen J, Vander Heyden Y, Gabriëls M, Camu F (2003) Preparation and in-vitro release rate of fentanyl-cyclodextrin complexes for prolonged action in epidural analgesia. Int J Pharm 265: 13-26.
14. Li P, Vishnuvajjala R, Tabibi SE, Yalkowsky SH (1998) Evaluation of in vitro precipitation methods. J Pharm Sci 87: 196-199.
15. Loftsson T, Frioriksdóttir H, Siguroardóttir AM, Ueda H (1994) The effect of water-soluble polymers on drug-cyclodextrin complexation. Int J Pharm 110: 169-177.
16. Loftsson T, Brewster ME (1996) Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 85: 1017-1025.
17. Loftsson T, Brewster ME (1997) Cyclodextrins as pharmaceutical excipients. Pharm Tech Eur 9: 26-34.
18. Ma DQ, Rajewski RA, Vander Velde D, Stella VJ (2000) Comparative Effects of (SBE)7m-β-CD and HP-β-CD on the stability of two anti-neoplastic agents, melphalan and carmustine. J Pharm Sci 89: 275-287.
19. Martin A, Swarbrick J, Cammarata A (1983) Physical Pharmacy, physical chemical principles in the pharmaceutical sciences. Lea & Febiger, Philadelpia, United States of America, pp. 314-351.
20. nd ed., Pharmaceutical Press, London, UK, pp. 661-667.
21. McCandless R, Yalkowsky SH (1998) Effect of hydroxypropyl-β- cyclodextrin and pH on the solubility of levemopamil HCl. J Pharm Sci 87: 1639-1642.
22. 7m-β-CD. J Pharm Sci 87: 926-930.
23. Okimoto K, Rajewski RA, Uekama K, Jona JA, Stella VJ (1996) The interaction of charged and uncharged drugs with neutral (HP-β-CD) and anionically charged (SBE7-β-CD) β-cyclodextrins. Pharm Res 13: 256-264.
24. Prancan AV, Ecanow B, Bernardoni RJ, Sadove MS (1980) Poloxamer 188 as vehicle for injectable diazepam. J Pharm Sci 69: 970-971.
25. Rajewski RA, Stella VJ (1996) Pharmaceutical applications of cyclodextrins. 2. In vivo delivery. J Pharm Sci 85: 1142-1169.
26. Rasool AA, Hussain AA, Dittert LW (1991) Solubility enhancement of some water-insoluble drugs in the presence of nicotinamide and related compounds. J Pharm Sci 80: 387-393.
27. Torres-Labandeira JJ, Davignon P, Pitha J (1990) Oversaturated solutions of drug in hydroxypropylcyclodextrins: parenteral preparation of pancratistatin. J Pharm Sci 80: 384-386.
28. Trapani G, Latrofa A, Franco M, Lopedota A, Sanna E and Liso G (1998) Inclusion complexation of propofol with 2-hydroxypropyl-β-cyclodextrin. J Pharm Sci 87: 514-518.
29. Trapani G, Latrofa A, Franco M, Pantaleo MR, Sanna E, Massa F, Tuveri F, Liso G (2000) Complexation of zolpidem with 2-hydroxypropyl-β-, methyl-β-, and hydroxypropyl-γ-cyclodextrin: effect on aqueous solubility, dissolution rate and ataxic activity in rat. J Pharm Sci 89: 1443-1451.
30. Van Sorge AA, EBLM Van Nispen tot Pannerden (1986) Parenterale diazepam: Valium®, diazepam FNA, Diazemuls® of Valium MM®. Pharm Weekblad 121: 157-160.
31. Yalkowsky SH, Valvani SC, Johnson BJ (1983) In vitro method for detecting precipitation of parenteral formulations after injection. J Pharm Sci 72: 1014-1017.
32. Yalkowsky SH, Krzyzaniak JF, Ward GH (1998) Formulation-related problems associated with intravenous drug delivery. J Pharm Sci 87: 787-796.
33. Yamamoto M, Yoshida A, Hirayama F, Uekama K (1989) Some physicochemical properties of branched β-cyclodextrins and their inclusion characteristics. Int J Pharm 49: 163-171.
34. Zia V, Rajewski RA, Bornancini ER, Luna EA, Stella VJ (1997) Effect of alkyl chain length and degree of substitution on the complexation of sulfoalkyl ether β-cyclodextrins with steroids. J Pharm Sci 86: 220-224.